Immune history shapes specificity of pandemic H1N1 influenza antibody responses

Journal of Experimental Medicine

Volumn 210, Issue 8, 2013, Pages 1493-1500

  Li, Yang ^a,b   Myers, Jaclyn L ^a   Bostick, David L ^c   Sullivan, Colleen B ^a   Madara, Jonathan ^a,b   Linderman, Susanne L ^a,b   Liu, Qin ^a   Carter, Donald M ^d,e   Wrammert, Jens ^f   Esposito, Susanna ^g   Principi, Nicola ^g   Plotkin, Joshua B ^c   Ross, Ted M ^d,e   Ahmed, Rafi ^f   Wilson, Patrick C ^h   Hensley, Scott E ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ANTIBODY RESPONSE; ARTICLE; FERRET; HUMAN; INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURAL HOMOLOGY; VIRUS ISOLATION;

AGE FACTORS; AMINO ACIDS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; EPITOPES; FEMALE; FERRETS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, MOLECULAR; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; PROTEIN CONFORMATION;

EID: 84884238986     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130212     Document Type: Article

References (30)

1. Baker, N.A., D. Sept, S. Joseph, M.J. Holst, and J.A. McCammon. 2001. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA. 98:10037-10041. http://dx.doi.org/10 .1073/pnas.181342398
2. Carter, D.M., H.R. Lu, C.E. Bloom, C.J. Crevar, J.L. Cherry, D.J. Lipman, and T.M. Ross. 2012. Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains. PLoS ONE. 7:e39435. http://dx.doi.org/10.1371/journal.pone.0039435
3. Carter, D.M., C.E. Bloom, E.J. Nascimento, E.T. Marques, J.K. Craigo, J.L. Cherry, D.J. Lipman, and T.M. Ross. 2013. Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J. Virol. 87:1400-1410. http://dx.doi.org/10.1128/JVI.02257-12
4. Caton, A.J., G.G. Brownlee, J.W. Yewdell, and W. Gerhard. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 31:417-427. http://dx.doi.org/10.1016/0092-8674(82)90135-0
5. Chen, Z., W. Wang, H. Zhou, A.L. Suguitan Jr., C. Shambaugh, L. Kim, J. Zhao, G. Kemble, and H. Jin. 2010. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J. Virol. 84:44-51. http://dx.doi.org/ 10.1128/JVI.02106-09
6. Dolinsky, T.J., P. Czodrowski, H. Li, J.E. Nielsen, J.H. Jensen, G. Klebe, and N.A. Baker. 2007. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35:W522-W525. http://dx.doi.org/10.1093/nar/gkm276
7. Esposito, S., C. Daleno, C. Tagliabue, A. Scala, I. Picciolli, F. Taroni, C. Galeone, F. Baldanti, and N. Principi. 2011. Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus. Virol. J. 8:563. http://dx.doi.org/10.1186/1743-422X-8-563
8. Essman, U., L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys. 103:8577- 8593. http://dx.doi.org/10.1063/1.470117
9. Fazekas de St. Groth, S., and R.G. Webster. 1966. Disquisitions of original antigenic sin. I. Evidence in man. J. Exp. Med. 124:331-345. http://dx.doi.org/10.1084/jem.124.3.331
10. Ferguson, N.M., A.P. Galvani, and R.M. Bush. 2003. Ecological and immunological determinants of influenza evolution. Nature. 422:428-433. http://dx.doi.org/10.1038/nature01509
11. Francis, T. 1960. On the Doctrine of Original Antigenic Sin. Proc. Am. Philos. Soc. 104:572.
12. Garten, R.J., C.T. Davis, C.A. Russell, B. Shu, S. Lindstrom, A. Balish, W.M. Sessions, X. Xu, E. Skepner, V. Deyde, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 325:197-201. http://dx.doi.org/10.1126/science.1176225
13. Hensley, S.E., S.R. Das, A.L. Bailey, L.M. Schmidt, H.D. Hickman, A. Jayaraman, K. Viswanathan, R. Raman, R. Sasisekharan, J.R. Bennink, and J.W. Yewdell. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science. 326:734-736. http://dx.doi.org/10.1126/science.1178258
14. Hess, B., C. Kutzner, D. van der Spoel, and E. Lindahl. 2008. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory Comput. 4:435-447. http://dx.doi.org/10.1021/ct700301q
15. Krause, J.C., T.M. Tumpey, C.J. Huffman, P.A. McGraw, M.B. Pearce, T. Tsibane, R. Hai, C.F. Basler, and J.E. Crowe Jr. 2010. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J. Virol. 84:3127-3130. http://dx.doi.org/10.1128/JVI.02184-09
16. Krause, J.C., T. Tsibane, T.M. Tumpey, C.J. Huffman, C.F. Basler, and J.E. Crowe Jr. 2011. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85:10905-10908. http://dx.doi.org/10.1128/JVI.00700-11
17. Li, G.M., C. Chiu, J. Wrammert, M. McCausland, S.F. Andrews, N.Y. Zheng, J.H. Lee, M. Huang, X. Qu, S. Edupuganti, et al. 2012. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA. 109:9047-9052. http://dx.doi.org/10.1073/pnas.1118979109
18. Manicassamy, B., R.A. Medina, R. Hai, T. Tsibane, S. Stertz, E. Nistal-Villán, P. Palese, C.F. Basler, and A. García-Sastre. 2010. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 6:e1000745. http://dx.doi.org/10.1371/journal.ppat.1000745
19. O'Donnell, C.D., L. Vogel, A. Wright, S.R. Das, J. Wrammert, G.M. Li, M. McCausland, N.Y. Zheng, J.W. Yewdell, R. Ahmed, P.C. Wilson, and K. Subbarao. 2012. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. MBio 3(3): e00120-12. http://dx.doi.org/10.1128/mBio.00120-12
20. Pica, N., R. Hai, F. Krammer, T.T. Wang, J. Maamary, D. Eggink, G.S. Tan, J.C. Krause, T. Moran, C.R. Stein, et al. 2012. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. USA. 109:2573-2578. http://dx.doi.org/10.1073/pnas.1200039109
21. Qiu, C., Y. Huang, Q. Wang, D. Tian, W. Zhang, Y. Hu, Z. Yuan, X. Zhang, and J. Xu. 2012. Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine. Clin. Infect. Dis. 54:17-24. http://dx.doi.org/10.1093/cid/cir753
22. Settembre, E.C., P.R. Dormitzer, and R. Rappuoli. 2011. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines. J Mol Cell Biol. 3:144-146. http://dx.doi.org/10.1093/jmcb/mjq046
23. Skountzou, I., D.G. Koutsonanos, J.H. Kim, R. Powers, L. Satyabhama, F. Masseoud, W.C. Weldon, Mdel.P. Martin, R.S. Mittler, R. Compans, and J. Jacob. 2010. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J. Immunol. 185:1642-1649. http://dx.doi.org/10.4049/jimmunol.1000091
24. Smith, G.J., D. Vijaykrishna, J. Bahl, S.J. Lycett, M. Worobey, O.G. Pybus, S.K. Ma, C.L. Cheung, J. Raghwani, S. Bhatt, et al. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 459:1122-1125. http://dx.doi.org/10.1038/nature08182
25. Stöhr, K., D. Bucher, T. Colgate, and J. Wood. 2012. Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol. Biol. 865:147-162. http://dx.doi.org/10.1007/978-1-61779-621-0_9
26. Tsibane, T., D.C. Ekiert, J.C. Krause, O. Martinez, J.E. Crowe Jr., I.A. Wilson, and C.F. Basler. 2012. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog. 8:e1003067. http://dx.doi.org/10.1371/journal.ppat.1003067
27. Wei, C.J., J.C. Boyington, K. Dai, K.V. Houser, M.B. Pearce, W.P. Kong, Z.Y. Yang, T.M. Tumpey, and G.J. Nabel. 2010. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2:ra21.
28. Whittle, J.R., R. Zhang, S. Khurana, L.R. King, J. Manischewitz, H. Golding, P.R. Dormitzer, B.F. Haynes, E.B. Walter, M.A. Moody, et al. 2011. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA. 108:14216-14221. http://dx.doi.org/10.1073/pnas.1111497108
29. Wrammert, J., D. Koutsonanos, G.M. Li, S. Edupuganti, J. Sui, M. Morrissey, M. McCausland, I. Skountzou, M. Hornig, W.I. Lipkin, et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208: 181-193. http://dx.doi.org/10.1084/jem.20101352
30. Xu, R., D.C. Ekiert, J.C. Krause, R. Hai, J.E. Crowe Jr., and I.A. Wilson. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science. 328:357-360. http://dx.doi.org/10.1126/science.1186430